Pure•SAL™
Pure•SAL™ was developed for the controlled and standardized collection of RNA or protein biomarkers from oral fluid specimens for subsequent stabilization and analysis in life science and research applications. The kit provides a simple, non-invasive platform for isolating liquid biopsy specimens — including cell free DNA, cell free RNA, exosomes, or proteins — in a single step.
Key Features
Liquid Biopsy Platform
Isolates cell free DNA, cell free RNA, exosomes, or proteins from saliva in a single non-invasive step.
Mucinous Filtration
Highly absorbent pad removes mucinous material that can interfere with downstream assays.
Proprietary Filtration Medium
Secondary filtration removes additional interferants and large molecules for a purified, ready-to-use specimen.
Flexible Storage
Purified sample is stabilized for immediate use or long-term storage pending downstream analysis.
For Research Use Only (RUO)
Pure•SAL™ is intended for research use only in the United States and is not FDA-cleared for diagnostic use.
Resources
Documentation
Publications
- 01 A Paper-Based Colorimetric Molecular Test for SARS-CoV-2 in Saliva (J. Wang 2021)
- 02 Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM (Wong D. 2020)
- 03 Human Salivary Protein Analysis Using RNAProSAL, PureSAL, and the Passive Drooling Method (Zohaib K. 2016)
- 04 A Simplified Method for the Isolation of Exosomes from Saliva (Laughlin M. 2015)
- 05 Saliva and Biofilm-Based Diagnostics: A Critical Review (Novy B. 2014)